The Launch of an Innovative Plant Based GOS for Infant Nutrition
22 Dec 2016 | Olygose
Olygose has developed and patented a plant-based alternative to beta-GOS by extracting pea serum alpha-galacto-oligosaccharides, a co-product of pea protein production (whose volumes are also increasing globally) for the infant milk formula market. Alpha-GOS is marketed under the P-GOS brand have a prebiotic profile similar to those of beta-GOS. It serves as an alternative to the beta-GOS in formulas for specific populations or for plant-based formulas. Beta-Galacto-oligosaccharides (GOS), produced from lactose, are now considered the reference prebiotic in infant formulas, due to their effects on the intestinal microbiota, as well as on several other physiological functions, such as intestinal transit or immunity. The volume of the GOS market is constantly increasing (forecast CAGR 14% between 2014 and 2020) and will reach a volume of about 80,000 tons by 2020. However, due to their dairy origin, beta-GOS is not currently used in specific formulas (ADDFMS) for the management of lactose intolerance or cow's milk protein allergy.
More videos
